Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
We will develop a novel approach to drug repurposing, utilising Natural Language Processing (NLP) and Literature Based Discovery (LBD) techniques. This will present a simplified, accessible drug repurposing pipeline using Word2Vec embeddings trained on PubMed abstracts to identify potential new medications to be repurposed. We present this approach in the context of antipsychotics, but it could be repeated for any available medication. The research is structured in three stages: 1. Identification of candidate medications using Word2Vec algorithm trained on scientific literature. 2. Empirical testing of identified candidates using a large hospital dataset to explore protective effects against disease onset. 3. Validation of findings using a second, independent dataset to assess generalizability. This method addresses limitations in current machine learning-based drug repurposing approaches, including lack of external validation and limited accessibility. By leveraging Word2Vec's ability to capture semantic relationships between words, the study aims to uncover hidden connections in medical literature that may lead to novel therapeutic discoveries. The protocol emphasizes transparency and reproducibility, utilizing publicly available electronic health record (EHR) databases for validation. This approach allows for tangible results even for researchers with limited machine learning expertise, bridging the gap between biomedical and information systems communities.
We will develop a novel approach to drug repurposing, utilising Natural Language Processing (NLP) and Literature Based Discovery (LBD) techniques. This will present a simplified, accessible drug repurposing pipeline using Word2Vec embeddings trained on PubMed abstracts to identify potential new medications to be repurposed. We present this approach in the context of antipsychotics, but it could be repeated for any available medication. The research is structured in three stages: 1. Identification of candidate medications using Word2Vec algorithm trained on scientific literature. 2. Empirical testing of identified candidates using a large hospital dataset to explore protective effects against disease onset. 3. Validation of findings using a second, independent dataset to assess generalizability. This method addresses limitations in current machine learning-based drug repurposing approaches, including lack of external validation and limited accessibility. By leveraging Word2Vec's ability to capture semantic relationships between words, the study aims to uncover hidden connections in medical literature that may lead to novel therapeutic discoveries. The protocol emphasizes transparency and reproducibility, utilizing publicly available electronic health record (EHR) databases for validation. This approach allows for tangible results even for researchers with limited machine learning expertise, bridging the gap between biomedical and information systems communities.
The rapid development of specific-purpose Large Language Models (LLMs), such as Med-PaLM, MEDITRON-70B, and Med-Gemini, has significantly impacted healthcare, offering unprecedented capabilities in clinical decision support, diagnostics, and personalized health monitoring. This paper reviews the advancements in medicine-specific LLMs, the integration of Retrieval-Augmented Generation (RAG) and prompt engineering, and their applications in improving diagnostic accuracy and educational utility. Despite the potential, these technologies present challenges, including bias, hallucinations, and the need for robust safety protocols. The paper also discusses the regulatory and ethical considerations necessary for integrating these models into mainstream healthcare. By examining current studies and developments, this paper aims to provide a comprehensive overview of the state of LLMs in medicine and highlight the future directions for research and application. The study concludes that while LLMs hold immense potential, their safe and effective integration into clinical practice requires rigorous testing, ongoing evaluation, and continuous collaboration among stakeholders.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.